Cancer risk-reducing surgery: Brazilian society of surgical oncology guideline part 1 (gynecology and breast).

Autor: Carneiro VCG; Department of Surgey, Gynecology, Oncology, Instituto de Medicina Integral Professor Fernando Figueira, Recife, Brazil.; Department of Pelvic Surgery, Hereditary Cancer Program, Hospital de Câncer de Pernambuco, Recife, Brazil.; Department of Oncogenetic, Oncology, Oncologia D'or, Rio de Janeiro, Brazil., Gifoni ACLVC; Department of Oncogenetic, Oncology, Oncologia D'or, Rio de Janeiro, Brazil., Mauro Rossi B; Department of Oncogenetic, Surgical Oncology, Hospital Sírio Libanês, São Paulo, Brazil., Andrade CEMDC; Department of Oncogynecology, Barretos Cancer Hospital, Barretos, Brazil., Lima FT; Department of Oncogenetic, Hospital Israelita Albert Einstein, São Paulo, Brazil.; Department of Oncogenetic, UNIFESP-EPM, São Paulo, Brazil., Galvão HCR; Department of Oncogenetic, DASA, São Paulo, Brazil., Casali da Rocha JC; Department of Oncogenetic, Abdominal Surgery, A. C. Camargo Cancer Center, São Paulo, Brazil., Silva Barreto LSD; Department of Surgery, HUOL/UFRN, Natal, Brazil., Ashton-Prolla P; Department of Genetic, Hospital de Clínicas de Porto Alegre/UFRGS, Porto Alegre, Brazil., Guindalini RSC; Department of Oncogenetic, Oncology, Oncologia D'or, Rio de Janeiro, Brazil., Farias TP; Department of Head and Neck, Oncological Surgery, INCA, Rio de Janeiro, Brazil., Andrade WP; Department of Surgery, Hospital Beneficência Portuguesa, São Paulo, Brazil.; Department of Surgery, Hospital Oswaldo Cruz, São Paulo, Brazil.; Department of Surgery, Hospital Santa Catarina, São Paulo, Brazil., Fernandes PHS; Department of Surgery, Universidade Federal de Uberlândia, Uberlândia, Brazil., Ribeiro R; Department of Surgical Oncology, Hospital Erasto Gaertner, Curitiba, Brazil., Lopes A; Department of Surgical Oncology, São Camilo Oncologia, São Paulo, Brazil., Tsunoda AT; Department of Surgical Oncology, Hospital Erasto Gaertner, Curitiba, Brazil.; Department of Surgery, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil., Azevedo BRB; Department of Surgical Oncology, Oncoclínicas, Curitiba, Brazil.; Department of Surgery, Pilar Hospital, Curitiba, Brazil., Marins CAM; Department of Head and Neck, Oncological Surgery, INCA, Rio de Janeiro, Brazil.; Department of Surgery, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil., Oliveira Uchôa DNA; Department of Surgery, Hospital Universitário Professor Alberto Antunes-UFAL, Maceió, Brazil., Dos Santos EAS; Department of Surgery, IMERV, Ribeirão Preto, Brazil., Fernández Coimbra FJ; Department of Oncogenetic, Abdominal Surgery, A. C. Camargo Cancer Center, São Paulo, Brazil., Dias Filho FA; Department of Surgery, Hospital Regional de Cacoal, Cacoal, Brazil., Lopes FCO; Department of Surgery, Hospital do Coração de Londrina, Londrina, Brazil., Fernandes FG; Department of Surgical Oncology, Hospital do Câncer-UOPECCAN, Cascavel, Brazil., Ritt GF; Department of Surgery, AMO/OSID, Salvador, Brazil., Laporte GA; Department of Surgery, Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil., Guimaraes GC; Department of Surgery, Hospital Beneficência Portuguesa, São Paulo, Brazil., Feitosa E Castro Neto H; Department of Surgical Oncology, Instituto do Câncer do Ceará, Fortaleza, Brazil., Dos Santos JC; Department of Surgery, HUPAA/UFAL, Maceió, Brazil., de Carvalho Vilela JB; Department of Surgical oncology, Hospital do Câncer Araújo Jorge, Goiânia, Brazil., Meinhardt Junior JG; Department of Surgery, Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil.; Department of Surgery, Hospital Santa Rita, Porto Alegre, Brazil., Cunha JRD; Department of Surgery, Universidade Federal de Uberlândia, Uberlândia, Brazil., Medeiros Milhomem L; Department of Surgery, Hospital das Clínicas da Universidade Federal de Goiás, Goiânia, Brazil., da Silva LM; Department of Pelvic Surgery, Hereditary Cancer Program, Hospital de Câncer de Pernambuco, Recife, Brazil., Maciel LF; Department of Head and Neck, Oncological Surgery, INCA, Rio de Janeiro, Brazil., Ramalho NM; Department of Surgey, Gynecology, Oncology, Instituto de Medicina Integral Professor Fernando Figueira, Recife, Brazil.; Department of Oncogenetic, Oncology, Oncologia D'or, Rio de Janeiro, Brazil., Leite Nunes R; Department of Surgery, GNDI Notredame Intermédica-Hospital Salvalus, São Paulo, Brazil., Guido de Araújo R; Department of Pelvic Surgery, Hereditary Cancer Program, Hospital de Câncer de Pernambuco, Recife, Brazil., de Assunção Ehrhardt R; Department of Pelvic Surgery, Hereditary Cancer Program, Hospital de Câncer de Pernambuco, Recife, Brazil., Delgado Bocanegra RE; Department of Surgery, Santa Casa de Misericórdia da Bahia, Salvador, Brazil., Silva Junior TC; Department of Surgery, Real Hospital Português de Pernambuco, Recife, Brazil., Oliveira VR; Department of Surgery, Hospital Universitário de Brasília, Brasília, Brazil., Silva Surimã W; Department of Surgery, Hospital Geral de Fortaleza, Fortaleza, Brazil., de Melo Melquiades M; Department of Oncogenetic, Hospital Albert Sabin, Juiz de Fora, Brazil., Ribeiro HSC; Department of Oncogenetic, Abdominal Surgery, A. C. Camargo Cancer Center, São Paulo, Brazil.; SBCO, 2021-2023 BBSO presidente, Rio de Janeiro, Brazil., Oliveira AF; Department of Surgery, Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil.; SBCO, 2019-2021 BBSO presidente, Rio de Janeiro, Brazil.

Publikováno v: Journal of surgical oncology [J Surg Oncol] 2022 Jul; Vol. 126 (1), pp. 10-19.

Prognostic factors in 291 patients with pulmonary metastases submitted to thoracotomy

Autor: Paulo Kowalski L, de Oliveira Regazzini Rc, Lopes A, Mauro Rossi B

Publikováno v: Sao Paulo Medical Journal v.113 n.3 1995
São Paulo medical journal
Associação Paulista de Medicina
instacron:APM
Scopus-Elsevier
São Paulo Medical Journal, Vol 113, Iss 3, Pp 910-916
Sao Paulo Medical Journal, Volume: 113, Issue: 3, Pages: 910-916, Published: JUN 1995

Pulmonary metastases are among the most common sites for the spread of cancer, particularly with mesenchymal tumors. Despite improvements in cancer therapy, the prognosis remains poor, except for the highly selective group of patients who are conside

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::426f0eae162c6bd05c917ed9f7ba75c5
https://pubmed.ncbi.nlm.nih.gov/8728726

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.